Close Menu

MilliporeSigma

NEW YORK (GenomeWeb News) – Sigma Life Science has reached a deal to license its CompoZr Zinc Finger Nuclease technology to Horizon Discovery on a non-exclusive basis, Sigma-Aldrich announced today.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported a 3 percent increase year over year in its second-quarter revenues as the company beat consensus analyst estimates on the top and bottom lines.

Gyros this week announced a partnership with EMD Millipore to develop, manufacture, and commercialize immunoassay kits for the Gyrolab platform.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said it is partnering with the Scripps Research Institute to develop and commercialize new reagents.

As the protease most commonly used to digest proteins into peptides for mass spec analysis, trypsin is a key part of most proteomic workflows, with the performance of the enzyme potentially affecting a variety experimental outcomes including sequence coverage and reproducibility.

DNAnexus has launched a developer program that offers bioinformaticians and software engineers the technical and support resources needed to create and integrate data analysis applications on its platform.

Roche this week launched new software updates, including advanced high-resolution melting analysis and qualitative detection modules, for the LightCycler 96 system.

NEW YORK (GenomeWeb News) – Cellular Dynamics today said that it has licensed certain genetic engineering patents from Life Technologies and Sigma-Aldrich, which the Madison, Wis.-based firm will use in creating human disease models and isogenic controls.

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday it has extended its global supply and distribution agreement with EMD Millipore.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific first contacted Life Technologies about a possible merger more than a year-and-a-half ago with a proposed deal at $58 per share, Life Technologies said in a proxy statement filed on Tuesday.

Pages

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.